1. Home
  2. DLNG vs SRZN Comparison

DLNG vs SRZN Comparison

Compare DLNG & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynagas LNG Partners LP

DLNG

Dynagas LNG Partners LP

HOLD

Current Price

$3.84

Market Cap

136.4M

ML Signal

HOLD

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$21.96

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLNG
SRZN
Founded
2013
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.4M
117.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
DLNG
SRZN
Price
$3.84
$21.96
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.50
AVG Volume (30 Days)
43.4K
113.8K
Earning Date
11-20-2025
11-07-2025
Dividend Yield
5.22%
N/A
EPS Growth
30.14
N/A
EPS
1.29
N/A
Revenue
$158,275,000.00
$3,604,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.37
N/A
P/E Ratio
$2.98
N/A
Revenue Growth
4.34
N/A
52 Week Low
$3.18
$5.90
52 Week High
$5.65
$24.94

Technical Indicators

Market Signals
Indicator
DLNG
SRZN
Relative Strength Index (RSI) 52.45 60.40
Support Level $3.79 $20.02
Resistance Level $4.02 $24.00
Average True Range (ATR) 0.08 1.93
MACD -0.01 -0.22
Stochastic Oscillator 32.26 39.03

Price Performance

Historical Comparison
DLNG
SRZN

About DLNG Dynagas LNG Partners LP

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: